.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Queensland Health
Merck
Baxter
Chubb
McKinsey
Medtronic
Citi
Express Scripts

Generated: June 24, 2017

DrugPatentWatch Database Preview

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Buprenorphine Hydrochloride And Naloxone Hydrochloride, and when can generic versions of Buprenorphine Hydrochloride And Naloxone Hydrochloride launch?

Buprenorphine Hydrochloride And Naloxone Hydrochloride is a drug marketed by Actavis Elizabeth, Kremers Urban Pharms, West-ward Pharms Int, Ethypharm Usa Corp, Sun Pharm Inds Ltd, Amneal Pharms, and Teva Pharms Usa. and is included in seven NDAs.

The generic ingredient in BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

Summary for Tradename: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Patents:0
Applicants:7
NDAs:7
Suppliers / Packagers: see list15
Clinical Trials: see list104,520
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL091422-001Feb 22, 2013ABRXNoNo► Subscribe► Subscribe
Ethypharm Usa Corp
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL204431-001Oct 16, 2015ABRXNoNo► Subscribe► Subscribe
Kremers Urban Pharms
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL205022-002Sep 19, 2016ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL203136-001Feb 22, 2013ABRXNoNo► Subscribe► Subscribe
Ethypharm Usa Corp
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride; naloxone hydrochloride
TABLET;SUBLINGUAL204431-002Oct 16, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Deloitte
McKesson
Julphar
Novartis
UBS
Johnson and Johnson
Fish and Richardson
Healthtrust
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot